Hospira Hosts Conference Call for First-Quarter Earnings
11 Abril 2005 - 1:48PM
PR Newswire (US)
Hospira Hosts Conference Call for First-Quarter Earnings LAKE
FOREST, Ill., April 11 /PRNewswire-FirstCall/ -- Hospira, Inc.
(NYSE:HSP), one of the largest hospital products manufacturers in
the United States, today announced that it will release its 2005
first-quarter financial results on Thursday, May 12, 2005, before
the U.S. stock market opens. A conference call featuring remarks by
senior management will be held with investors and the media that
same day at 9 a.m. Central Time. A live webcast of the conference
call will be available online at http://www.hospira.com/ or through
Thomson's individual investor center at
http://www.companyboardroom.com/. Listeners should log on
approximately 10 minutes in advance to ensure proper computer setup
to receive the webcast. A replay will be available for 30 days
following the call. About Hospira Hospira, Inc. is a global
specialty pharmaceutical and medication delivery company dedicated
to Advancing Wellness(TM) by developing, manufacturing and
marketing products that help improve the productivity, safety and
efficacy of patient care. Created from the core global hospital
products business of Abbott Laboratories in April 2004, Hospira is
a new company with 70 years of service to the hospital industry.
The company's portfolio includes one of the industry's broadest
lines of generic acute-care injectables, which help address the
high cost of proprietary pharmaceuticals in hospitals; integrated
solutions for medication management and infusion therapy; and the
leading U.S. injectable contract manufacturing business.
Headquartered in Lake Forest, Ill., north of Chicago, Hospira has
approximately 14,000 employees and 15 manufacturing facilities
worldwide. Hospira's news releases and other information can be
found at http://www.hospira.com/. Private Securities Litigation
Reform Act of 1995 -- A Caution Concerning Forward-Looking
Statements Some statements in this news release may be
forward-looking statements for purposes of the Private Securities
Litigation Reform Act of 1995. Hospira cautions that these
forward-looking statements are subject to risks and uncertainties
that may cause actual results to differ materially from those
indicated in the forward-looking statements. Economic, competitive,
governmental, technological and other factors that may affect
Hospira's operations and may cause actual results to be materially
different from expectations include the risks and uncertainties set
forth under the heading "Item 1 Business -- Risk Factors" in
Hospira's Annual Report on Form 10-K for the year ended Dec. 31,
2004, filed with the Securities and Exchange Commission, which are
incorporated by reference. Hospira undertakes no obligation to
release publicly any revisions to forward-looking statements as the
result of subsequent events or developments.
http://www.newscom.com/cgi-bin/prnh/20040503/HSPLOGO
http://photoarchive.ap.org/ DATASOURCE: Hospira, Inc. CONTACT:
Media, Tareta Adams, +1-224-212-2535, or Financial Community, Lynn
McHugh, +1-224-212-2363, both of Hospira, Inc. Web site:
http://www.hospira.com/
Copyright
Hospira (NYSE:HSP)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Hospira (NYSE:HSP)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024
Notícias em tempo-real sobre da New York Stock Exchange bolsa de valores: 0 artigos recentes
Mais Notícias de Hospira W/I